Medi-Caps Limited (MEDICAPQ.BO)
INR 41.9
(-0.76%)
INR 41.9
(-0.76%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.77 Million INR | -100.57% |
| 2022 | 67.91 Million INR | -47.63% |
| 2021 | 119.69 Million INR | -12.42% |
| 2020 | 128.63 Million INR | 548.57% |
| 2019 | -38.96 Million INR | -143.3% |
| 2018 | 74.55 Million INR | 108.62% |
| 2017 | 32.4 Million INR | 35.48% |
| 2016 | 36.25 Million INR | -26.44% |
| 2015 | 32.88 Million INR | 513.26% |
| 2014 | 12.07 Million INR | -88.64% |
| 2013 | 25.3 Million INR | 8.31% |
| 2012 | 23.06 Million INR | -11.28% |
| 2011 | 41.38 Million INR | -24.41% |
| 2010 | 50.4 Million INR | 52.75% |
| 2009 | 54.55 Million INR | -4.8% |
| 2008 | 55.23 Million INR | -43.02% |
| 2007 | 167.36 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.76 Million INR | 49.83% |
| 2023 FY | - INR | -100.57% |
| 2023 Q1 | -6.61 Million INR | -318.92% |
| 2023 Q2 | 5.68 Million INR | 185.95% |
| 2023 Q3 | 7.94 Million INR | 39.61% |
| 2023 Q4 | -5.03 Million INR | -163.41% |
| 2022 Q3 | 18.4 Million INR | -31.17% |
| 2022 Q4 | 3.02 Million INR | -83.58% |
| 2022 FY | - INR | -47.63% |
| 2022 Q1 | 11.35 Million INR | -18.71% |
| 2022 Q2 | 26.74 Million INR | 135.52% |
| 2021 Q2 | 41.63 Million INR | 10.93% |
| 2021 Q4 | 13.96 Million INR | -45.33% |
| 2021 FY | - INR | -12.42% |
| 2021 Q1 | 37.53 Million INR | 37.05% |
| 2021 Q3 | 25.55 Million INR | -38.63% |
| 2020 Q2 | 34.96 Million INR | 26.93% |
| 2020 FY | - INR | 548.57% |
| 2020 Q4 | 27.38 Million INR | -28.0% |
| 2020 Q3 | 38.03 Million INR | 8.77% |
| 2020 Q1 | 27.54 Million INR | 381.26% |
| 2019 FY | - INR | -143.3% |
| 2019 Q1 | 11.2 Million INR | -53.43% |
| 2019 Q2 | -17.88 Million INR | -259.64% |
| 2019 Q4 | 5.72 Million INR | 120.23% |
| 2019 Q3 | -28.3 Million INR | -58.28% |
| 2018 Q1 | -12.67 Million INR | 0.0% |
| 2018 Q4 | 24.05 Million INR | -1.13% |
| 2018 Q3 | 24.32 Million INR | -23.7% |
| 2018 Q2 | 31.88 Million INR | 351.53% |
| 2018 FY | - INR | 108.62% |
| 2017 FY | - INR | 35.48% |
| 2016 FY | - INR | -26.44% |
| 2015 FY | - INR | 513.26% |
| 2014 FY | - INR | -88.64% |
| 2013 FY | - INR | 8.31% |
| 2012 FY | - INR | -11.28% |
| 2012 Q4 | 46.64 Million INR | 652.99% |
| 2012 Q3 | -8.43 Million INR | 0.0% |
| 2011 Q4 | 12.52 Million INR | 18.44% |
| 2011 FY | - INR | -24.41% |
| 2011 Q3 | 10.57 Million INR | 0.0% |
| 2010 FY | - INR | 52.75% |
| 2009 FY | - INR | -4.8% |
| 2008 FY | - INR | -43.02% |
| 2007 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 638.75 Thousand INR | -646.923% |
| Sastasundar Ventures Limited | -203.51 Million INR | 102.344% |
| KIMIA BIOSCIENCES LIMITED | 11.58 Million INR | 58.814% |
| SHELTER PHARMA LIMITED | 89.01 Million INR | 94.64% |
| Vasundhara Rasayans Limited | 84.22 Million INR | 94.335% |
| Sunil Healthcare Limited | 93.07 Million INR | 94.874% |
| Chemo Pharma Laboratories Limited | 16.51 Million INR | 71.116% |
| MedPlus Health Services Limited | 3.94 Billion INR | 99.879% |
| Zenith Healthcare Limited | 4.98 Million INR | 4.35% |
| Patidar Buildcon Limited | -5.52 Million INR | 186.337% |
| Sanjivani Paranteral Limited. | 87.58 Million INR | 94.553% |
| Roopa Industries Limited | 55.7 Million INR | 91.435% |
| Smruthi Organics Limited | 120.31 Million INR | 96.034% |
| Trident Lifeline Limited | 102.69 Million INR | 95.354% |
| Bacil Pharma Limited | -569.32 Thousand INR | 938.017% |
| Pharmaids Pharmaceuticals Limited | -123.28 Million INR | 103.87% |
| Gujarat Terce Laboratories Limited | 15.87 Million INR | 69.95% |
| Bharat Immunologicals & Biologicals Corporation Limited | -151.05 Million INR | 103.158% |
| Sandu Pharmaceuticals Limited | 27.19 Million INR | 82.455% |
| PANJON LTD. | 4.08 Million INR | -16.679% |
| Tyche Industries Limited | 128.2 Million INR | 96.279% |
| Trimurthi Limited | -2.47 Million INR | 292.495% |
| TIAAN CONSUMER LIMITED | -19.05 Million INR | 125.042% |
| Anuh Pharma Limited | 878.5 Million INR | 99.457% |
| Crestchem Limited | 30.33 Million INR | 84.272% |
| Emmessar Biotech & Nutrition Limited | -10.81 Million INR | 144.102% |
| Zenlabs Ethica Limited | 27.09 Million INR | 82.392% |
| Vikram Thermo (India) Limited | 386.92 Million INR | 98.767% |
| ANG Lifesciences India Limited | 90.66 Million INR | 94.738% |
| Parmax Pharma Limited | 22.93 Million INR | 79.2% |
| Fredun Pharmaceuticals Limited | 388.97 Million INR | 98.773% |
| Deccan Health Care Limited | 37.5 Million INR | 87.279% |
| Shukra Pharmaceuticals Limited | 216.59 Million INR | 97.797% |
| Norris Medicines Limited | -1.78 Million INR | 367.411% |
| SUDARSHAN PHARMA INDUSTRIES LI | 254.17 Million INR | 98.123% |
| Veerhealth Care Limited | 15.99 Million INR | 70.172% |
| Makers Laboratories Limited | 25.81 Million INR | 81.516% |
| Lactose (India) Limited | 201.22 Million INR | 97.629% |
| OXYGENTA PHARMACEUTICAL LIMITE | -96.17 Million INR | 104.961% |
| Ambalal Sarabhai Enterprises Limited | 170.57 Million INR | 97.203% |
| Mercury Laboratories Limited | 101.18 Million INR | 95.285% |
| Gennex Laboratories Limited | 219.35 Million INR | 97.825% |
| PRAVEG LIMITED | 321.43 Million INR | 98.516% |
| Denis Chem Lab Limited | 224.84 Million INR | 97.878% |
| Kwality Pharmaceuticals Limited | 610.44 Million INR | 99.218% |
| Jenburkt Pharmaceuticals Limited | 377.86 Million INR | 98.737% |
| Colinz Laboratories Limited | 5.42 Million INR | 12.104% |
| Godavari Drugs Limited | 134.62 Million INR | 96.456% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 1275.123% |
| Zenotech Laboratories Limited | 172.64 Million INR | 97.237% |
| Panchsheel Organics Limited | 189.36 Million INR | 97.481% |
| Shree Ganesh Remedies Limited | 448.77 Million INR | 98.937% |
| Vivanza Biosciences Limited | 11.2 Million INR | 57.417% |
| Phaarmasia Limited | -1.58 Million INR | 401.58% |
| Bharat Parenterals Limited | 265.74 Million INR | 98.205% |
| DECIPHER LABS LIMITED | -2.72 Million INR | 275.404% |
| Gujarat Themis Biosyn Limited | 830.99 Million INR | 99.426% |
| BDH Industries Limited | 124.27 Million INR | 96.161% |
| Vista Pharmaceuticals Limited | -32.37 Million INR | 114.735% |
| Coral Laboratories Limited | 227.07 Million INR | 97.899% |
| Concord Drugs Limited | 40.52 Million INR | 88.226% |
| Beryl Drugs Limited | 26.63 Million INR | 82.09% |
| Evoq Remedies Limited | 6.18 Million INR | 22.899% |
| Add-Shop E-Retail Limited | 82.61 Million INR | 94.225% |
| Transchem Limited | 56.61 Million INR | 91.572% |
| Ishita Drugs and Industries Limited | 11.88 Million INR | 59.867% |
| Parnax Lab Limited | 243.59 Million INR | 98.041% |
| Source Natural Foods and Herbal Supplements Limited | 44.8 Million INR | 89.351% |
| Kerala Ayurveda Limited | 70.78 Million INR | 93.26% |
| Cian Healthcare Limited | 122.56 Million INR | 96.107% |
| Trinity League India Limited | -26.25 Million INR | 118.173% |
| Syschem (India) Limited | 70.4 Million INR | 93.223% |
| KOBO BIOTECH LIMITED | -8.57 Million INR | 155.651% |
| Natural Capsules Limited | 219.9 Million INR | 97.83% |
| Auro Laboratories Limited | 121.73 Million INR | 96.081% |